Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The peptide problem: Hype is outrunning the evidence What is BPC 157 (Body Protection Compound) and how can it help? Axon Integrative Health LLC The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Action Alert: Protect Access to Compounded Peptides Federal regulators are making decisions right now that could determine the future of peptide based therapies in the U.S. Compounded peptides such as BPC 157 and epitalon